Data-sharing requests relating to data in this manuscript will be considered after the publication date and either (1) when this product and indication (or other new use) have been granted marketing authorization in both the US and Europe, or (2) when clinical development discontinues and the data will not be submitted to regulatory authorities
These medicines can improve blood sugar control, support weight reduction, and lower cardiovascular or kidney risk in the right patient
A study published in January found the drugs reduced the risk of 42 diseases, including heart disease, cancer, clotting disorders, Alzheimers, chronic kidney disease, addiction and a range of psychiatric conditions
KilicKKaratasHDnmez-DemirBEren-KocakEGursoy-OzdemirYCanAet al
trial data do not describe product data